Mutual fund holdings in BALAXI PHARMACEUTICALS LIMITED: who holds it and who bought and sold in Sep 2026, with its other institutional holdings, each beside the price.
₹20.50▲ +1.2%
NSE close, 4 Nov 2026 · delivery 89.6% · 1-year range ₹15.67 – ₹43.08
Data as of10 sources, each card shows its own date
MF: Sep 2026 portfolios (monthly), 45 fund houses coveredShares outstanding: NSE equity list, 4 Nov 2026Delivery: NSE security-wise delivery, 4 Nov 2026 · 243 days collectedDeals: NSE deal files, 4 Nov 2026SLBM: NSE, 4 Nov 2026 · 56 days collectedMTF: NSE, 3 Nov 2026 · 55 days collectedFlags: NSE, 4 Nov 2026FPI: Shareholding pattern as of 30 Sep 2026, filed 17 Oct 2026Pledge: Shareholding pattern as of 30 Sep 2026Insider: Trades dated 7 Aug 2026 to 4 Nov 2026 (disclosures collected since 3 May 2026)
MF holding, % of equity
None held
Sep 2026
FPI holding, % of equity
0.00%■ 0.00 pp
as of 30 Sep 2026
Fund houses holding
0
0 entered, 0 exited · Sep 2026
Promoter pledge
0.00%■ 0.00 pp
as of 30 Sep 2026
Delivery
89.6%▲ +10.0 pp
4 Nov 2026
MTF book
—
NSE listed no margin trading position for BALAXI PHARMACEUTICALS LIMITED on any of the 55 days collected, 14 Aug 2026 to 3 Nov 2026.
Questions about BALAXI PHARMACEUTICALS LIMITED
from the figures on this page
What is the FII, DII and promoter holding in BALAXI PHARMACEUTICALS LIMITED?
At the Sep 2026 quarter end (NSE shareholding pattern, change vs Jun 2026): promoters 65.99% (unchanged); FIIs 0.00% (unchanged); DIIs 2.56% (unchanged); individuals up to Rs 2 lakh 18.48% (−0.29 pp); other public 12.97% (+0.29 pp).
Mutual funds
i
What it is. Shares of this company held by mutual funds, taken from the portfolio each fund house publishes for every month end. Some index-only schemes publish only every quarter. "Houses" counts the fund houses holding it in an active scheme.
How to read it. "% of equity" is the shares funds hold divided by all the company's shares. A change between two months compares only the houses with a portfolio in both months. Share counts move when funds add to or cut a holding, or when a split or bonus is applied.
Does not show: Trades inside the month, or why a fund changed its holding.
AMC portfolios, Sep 2026 · 45 fund houses covered
No tracked fund house held BALAXI in Sep 2026.
Price
NSE close by day · 30 Oct 2025 to 4 Nov 2026
₹20.50 NSE close, 4 Nov 2026
30 Oct 20254 Nov 2026
₹15.67 to ₹43.08, split or bonus adjusted. Since first held = the close at the end of the first month any tracked fund held it, to the latest close.
Shareholders
Shareholding
i
What it is. Every listed company reports how its shares are split between promoters and the public, within 21 days of each quarter end (companies on the SME exchanges report every half year). This page groups the public part into foreign investors, Indian institutions and retail.
How to read it. Percentages are of the filing's share base. The change column compares with the previous quarter.
Does not show: Trades between quarters.
as of Sep 2026 · Source: NSE shareholding pattern
Category
% of filed shares
Change, pp
Promoter and promoter group
65.99%
0.00 pp
Foreign portfolio investors (FPI)
0.00%
0.00 pp
Domestic institutions (DII)
2.56%
0.00 pp
of which Banks
0.02%
0.00 pp
of which Alternative investment funds
2.54%
0.00 pp
Resident individuals up to Rs 2 lakh (as the filing defines it)
18.48%
−0.29 pp
Other public (derived)
12.97%
+0.29 pp
% of the filing's shares (ADR, GDR left out) at Sep 2026; pp change against Jun 2026.
How this is counted
Share of the company's shares as filed in its quarterly shareholding pattern (depository-receipt shares are outside the filing's base, so its mutual fund line can sit above the MF holding elsewhere on this page, which is a % of all equity shares). "of which" lines sit inside Domestic institutions. A dash means the filing has no such line, Other public cannot be worked out from the filed lines, or there is no previous quarter to compare.
No line in this filing, so not shown: Mutual funds / UTI, Insurance companies, Provident and pension funds.
Quarter by quarter
66%66%0
Mar 2026Jun 2026Sep 2026
Promoter and promoter group Foreign portfolio investors (FPI) Domestic institutions (DII) Resident individuals up to Rs 2 lakh Other public (derived), % of shares
History from Mar 2026: 3 quarters. Hover a row for every stored quarter.
Named FPIs at 1% or more
i
What it is. Foreign portfolio investors (FPIs) are overseas investors registered with SEBI. The shareholding pattern names every public holder with 1% or more of the company; this card shows the FPIs among them.
How to read it. Filed once a quarter. "Joined" means named this quarter and not last, which can also mean the holder crossed 1% rather than bought a first share. "Left" can likewise mean it fell below 1%.
Does not show: Holdings below 1%, or trades between quarters.
as of 30 Sep 2026
Foreign investors who own 1% or more, from the quarterly shareholding pattern. Shows which large foreign funds are on the register.
0.00%■ 0.00 pp vs 30 Jun 2026
FPI category I + II, % of total shares · 0 named at 1% or more
No FPI held 1% or more of BALAXI PHARMACEUTICALS LIMITED on 30 Sep 2026.
Shareholding pattern as of 30 Sep 2026, filed 17 Oct 2026
FPI holding vs price
Mar 2026 to Sep 2026
Share of the company held by foreign portfolio investors at each quarter end.
0%0%
Mar 2026Jun 2026Sep 2026
FPI holding
Promoter pledge
i
What it is. Promoters sometimes borrow money against their shares by pledging them: the lender holds the shares as security. Promoters report a pledge or its release to the exchange within seven working days, and the quarterly shareholding pattern shows the shares pledged or otherwise encumbered.
How to read it. Shown as a share of the promoter holding and of all the company's shares, once a quarter. Compare quarters to see the direction.
Does not show: The size of the loan, or the lender's terms.
as of 30 Sep 2026
Share of the promoters' stake pledged as loan collateral. A rising number means more of the owners' shares are borrowed against.
0.00%■ 0.00 pp vs 30 Jun 2026
of promoter holding · 0.00% of total shares
Promoters had pledged 0 of their 3.64 cr shares on 30 Sep 2026.
Shareholding pattern as of 30 Sep 2026
Delivery
Delivery
i
What it is. Of all shares traded in a day, the part that was settled by delivery: the buyer receives the shares in their demat account. NSE counts this per client, so the rest is shares a client bought and sold within the same day (intraday).
How to read it. NSE publishes the share for every stock every day. Stocks differ in how much they are traded within the day, so compare a stock with its own past rather than with another stock. A 5-day figure smooths out single-day noise.
Does not show: Who the buyers were, or whether they plan to keep the shares.
4 Nov 2026
Share of the day's traded volume taken into demat instead of squared off the same day. A higher share means more of the trading was buying to hold.
89.6%▲ +10.0 pp vs 20-day average
20-day average 79.6% · 92nd percentile of 243 days collected
7 Oct 20264 Nov 2026
By month over 59 months (Aug 2021 to Oct 2026), 63.8% of shares traded were delivered; lowest month 31.6% (Jan 2025), highest 89.4% (Mar 2025).
Share of each session's traded shares taken into demat. High delivery on a falling price means holders took the shares, not just day traders.
98%98%77%56%
₹25.80₹25.80₹22.48₹19.15
21 Aug4 Sep21 Sep6 Oct21 Oct4 Nov
Delivery NSE close, right scale
F&O and margin
Red flags
i
What it is. Exchange lists that restrict trading in a stock: the F&O ban (no fresh F&O positions), and the Additional and Graded Surveillance Measures (ASM and GSM), which tighten trading conditions with steps such as higher margins, narrower price bands and trade-for-trade settlement.
How to read it. The card shows whether the stock is on a list today, from the exchange's daily files.
Does not show: Anything about the company beyond being listed.
4 Nov 2026
The exchange's own lists: F&O ban and surveillance. They say the stock is on a list, not why it moved.
No F&O
BALAXI PHARMACEUTICALS LIMITED has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed BALAXI PHARMACEUTICALS LIMITED under no ASM or GSM stage on 4 Nov 2026. Pledge invocations are not available yet.
NSE, 4 Nov 2026
Nothing to show for BALAXI PHARMACEUTICALS LIMITED in the period checkedBulk and block deals: No bulk or block deals in BALAXI PHARMACEUTICALS LIMITED from 7 Aug 2026 to 4 Nov 2026. · Insider and promoter: No insider or promoter trade in BALAXI PHARMACEUTICALS LIMITED dated 7 Aug 2026 to 4 Nov 2026 was disclosed. · MTF book: NSE listed no margin trading position for BALAXI PHARMACEUTICALS LIMITED on any of the 55 days collected, 14 Aug 2026 to 3 Nov 2026. · SLBM borrowing: NSE listed no securities-lending (SLB) open position for BALAXI PHARMACEUTICALS LIMITED on any of the 56 days collected, 14 Aug 2026 to 4 Nov 2026. No SLBM trades in BALAXI PHARMACEUTICALS LIMITED on 4 Nov 2026.
On NSE ↗
NSE's own public pages for BALAXI; this site does not copy them
